Godavari Drugs

23
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE362C01012
  • NSEID:
  • BSEID: 530317
INR
81.10
-0.81 (-0.99%)
BSENSE

Dec 23

BSE+NSE Vol: 1.53 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -27.67% vs -1.82% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -11.10% vs 34.11% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -3.72% vs 25.15% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -21.07% vs 46.57% in Mar 2024

Compare Profit and Loss Results of Godavari Drugs
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
113.00
61.00
52.00
85.25%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
113.00
61.00
52.00
85.25%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
0.00
-3.00
0%
Raw Materials Consumed
85.00
38.00
47.00
123.68%
Power & Fuel Cost
6.00
0.00
6.00
0%
Employee Cost
5.00
8.00
-3.00
-37.50%
Operating Expenses
3.00
1.00
2.00
200.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
1.00
-1.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
3.00
0.00
3.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
101.00
51.00
50.00
98.04%
Operating Profit (PBDIT) excl Other Income
11.00
10.00
1.00
10.00%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
12.00
11.00
1.00
9.09%
Interest
4.00
2.00
2.00
100.00%
Profit before Depriciation and Tax
8.00
9.00
-1.00
-11.11%
Depreciation
2.00
3.00
-1.00
-33.33%
Profit Before Taxation & Exceptional Items
5.00
6.00
-1.00
-16.67%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
6.00
-1.00
-16.67%
Provision for Tax
1.00
1.00
0.00
0.00%
Profit After Tax
4.00
4.00
0.00
0.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
20.00
9.00
11.00
122.22%
Profit Available for appropriations
24.00
14.00
10.00
71.43%
Appropriations
24.00
14.00
10.00
71.43%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
5.82
3.31
2.51
75.83%
Profit And Loss - Net Sales
Net Sales 113.35 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -27.67% vs -1.82% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.83 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.10% vs 34.11% in Mar 2024

Profit And Loss - Interest
Interest 4.73 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -3.72% vs 25.15% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 4.38 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -21.07% vs 46.57% in Mar 2024